Chemical based system for detecting nucleic acids and single nucleotide polymorphisms

Google Cloud for Life Sciences offers advanced solutions aimed at enhancing drug discovery and precision medicine through two primary suites: the Target and Lead Identification Suite and the Multiomics Suite. The Target and Lead Identification Suite focuses on in silico drug design, allowing researchers to predict antibody structures, optimize lead candidates, and conduct quantitative structure-activity relationship (QSAR) studies efficiently. This suite leverages high-performance computing (HPC) resources to streamline workflows, reduce costs, and improve the accuracy of predictions, ultimately accelerating the drug discovery process. Meanwhile, the Multiomics Suite transforms multiomics data into actionable insights, facilitating the analysis of genomic data and the advancement of personalized medicine. It enables researchers to collaborate effectively, interpret complex datasets, and drive efficiencies in scientific discovery.

Both suites are designed to support scalable and reproducible workflows, enhancing the capabilities of life sciences organizations. The Target and Lead Identification Suite optimizes resource utilization for lead discovery, while the Multiomics Suite employs cloud computing and artificial intelligence to accelerate genomic analysis and improve precision medicine-guided drug development. By integrating these technologies, Google Cloud empowers healthcare and life sciences organizations to unlock the full potential of their data, streamline operations, and ultimately improve patient outcomes through innovative solutions.

United States

Process, analyze, and annotate genomics and biomedical data at scale using containerized workflows.

Google - Cloud LIfe Sciences

Company Details